<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(11)</volume><submitter>Huguet A</submitter><pubmed_abstract>Myotonic dystrophy type 1 (DM1) is caused by an unstable CTG repeat expansion in the 3'UTR of the DM protein kinase (DMPK) gene. DMPK transcripts carrying CUG expansions form nuclear foci and affect splicing regulation of various RNA transcripts. Furthermore, bidirectional transcription over the DMPK gene and non-conventional RNA translation of repeated transcripts have been described in DM1. It is clear now that this disease may involve multiple pathogenic pathways including changes in gene expression, RNA stability and splicing regulation, protein translation, and micro-RNA metabolism. We previously generated transgenic mice with 45-kb of the DM1 locus and >300 CTG repeats (DM300 mice). After successive breeding and a high level of CTG repeat instability, we obtained transgenic mice carr</pubmed_abstract><journal>PLoS genetics</journal><pagination>e1003043</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3510028</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.</pubmed_title><pmcid>PMC3510028</pmcid><pubmed_authors>Gomes-Pereira M</pubmed_authors><pubmed_authors>Medja F</pubmed_authors><pubmed_authors>Decostre V</pubmed_authors><pubmed_authors>Nicole A</pubmed_authors><pubmed_authors>Vignaud A</pubmed_authors><pubmed_authors>Hoeflich A</pubmed_authors><pubmed_authors>Puymirat J</pubmed_authors><pubmed_authors>Bassez G</pubmed_authors><pubmed_authors>Munnich A</pubmed_authors><pubmed_authors>Furling D</pubmed_authors><pubmed_authors>Gourdon G</pubmed_authors><pubmed_authors>Ferry A</pubmed_authors><pubmed_authors>Metzger F</pubmed_authors><pubmed_authors>Huguet A</pubmed_authors><pubmed_authors>Hogrel JY</pubmed_authors><pubmed_authors>Baraibar M</pubmed_authors><pubmed_authors>Guiraud-Dogan C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.</name><description>Myotonic dystrophy type 1 (DM1) is caused by an unstable CTG repeat expansion in the 3'UTR of the DM protein kinase (DMPK) gene. DMPK transcripts carrying CUG expansions form nuclear foci and affect splicing regulation of various RNA transcripts. Furthermore, bidirectional transcription over the DMPK gene and non-conventional RNA translation of repeated transcripts have been described in DM1. It is clear now that this disease may involve multiple pathogenic pathways including changes in gene expression, RNA stability and splicing regulation, protein translation, and micro-RNA metabolism. We previously generated transgenic mice with 45-kb of the DM1 locus and >300 CTG repeats (DM300 mice). After successive breeding and a high level of CTG repeat instability, we obtained transgenic mice carr</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012</publication><modification>2025-07-06T03:05:35.46Z</modification><creation>2025-07-06T03:05:35.46Z</creation></dates><accession>S-EPMC3510028</accession><cross_references><pubmed>23209425</pubmed><doi>10.1371/journal.pgen.1003043</doi></cross_references></HashMap>